HealthQuill Drugs
Using artificial intelligence Stanford researchers have developed a “digital twin” of a part of a mouse brain that processes visual information.
Drugs Health Pharma

Stanford researchers build ‘digital twin’ of a part of mouse brain

HQ Team April 15, 2025: Using artificial intelligence Stanford researchers have developed a “digital twin” of a part of a mouse brain that.

Read More
Harvard University has rejected demands from US President Donald Trump’s administration that threaten $9 billion in research funding.
Drugs Health Pharma

Harvard rejects Trump’s demands that threaten $9b research funding

HQ Team April 15, 2025: Harvard University has rejected demands from US President Donald Trump’s administration that threaten $9 billion in research funding..

Read More
Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of the heart's main pumping chamber becomes abnormally thickened, has failed to meet its goals.
Drugs Health Medical

Bristol Myers’ test drug to treat a type of heart disease fails to meet goals

HQ Team April 15, 2025: Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of.

Read More
A new pandemic like Covid-19 is “not a theoretical risk, it is an epidemiological certainty,” said the World Health Organization’s Director-General, Dr Tedros Adhanom Ghebreyesus.
Climate Drugs Health

A new pandemic like Covid-19 is ‘epidemiological certainty’: WHO

HQ Team April 13, 2025: A new pandemic like Covid-19 is “not a theoretical risk, it is an epidemiological certainty,” said the World.

Read More
Novo Nordisk will invest 6.4 billion reais ($1.05 billion) in Brazil’s Monte Claros to expand its production of injectable treatments for people living with obesity and chronic diseases.
Drugs Medical Pharma

Novo Nordisk to invest $1.05b in Monte Claros facility in Brazil

HQ Team April 10, 2025: Novo Nordisk will invest 6.4 billion reais ($1.05 billion) in Brazil’s Monte Claros to expand its production of.

Read More
The United Nations has warned that “unprecedented” global aid cuts could derail a three-year trend of a 40% decline in maternal deaths as one maternal death occurred every two minutes worldwide in 2023.
Drugs Health Pharma

Maternal mortality rates may fail UN goal, global aid cuts the main culprit 

HQ Team April 9, 2025: The United Nations has warned that “unprecedented” global aid cuts could derail a three-year trend of a 40%.

Read More
AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from the European Union.
Drugs Health Pharma

AstraZeneca’s lung cancer drug combination gets EU approval 

HQ Team April 4, 2025: AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from.

Read More
Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European Union, the companies announced.
Drugs Medical Pharma

EU green lights AstraZeneca, Daiichi’s treatment for breast cancer

HQ Team April 4, 2025: Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European.

Read More
Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and Drug Administration, according to a statement.
Drugs Health Medical

Amgen gets US approval to treat immunoglobulin G4-related disease 

HQ Team April 4, 2025: Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and.

Read More
The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating dry eyes, over concerns with the data from the trial.
Drugs Health Medical

Aldeyra Therapeutics’ dry eye treatment rejected by USFDA

HQ Team April 3, 2025: The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating.

Read More